Please login to the form below

Not currently logged in

Pfizer India selects Aijaz Tobaccowalla as managing director

He will take over from Kewal Handa, who retires in August

Pfizer has appointed Aijaz Tobaccowalla to lead its Mumbai-headquartered Indian operations, taking over from Kewal Handa who will retire in August.

Tobaccowalla has more than 20 years' experience in the pharma industry, almost all of them spent at either Pfizer or Wyeth, which Pfizer acquired in 2009.

Ahmet Goksun, regional president of Pfizer's Emerging Markets Europe, Russia, India and Turkey (EURIT) unit, said: “Aijaz, 'Jazz', is a seasoned leader who will continue to lead Pfizer India through this exciting period. His leadership experience, demonstrated versatility, and successful management in a constantly changing business environment, make him the ideal leader for Pfizer India.

“We thank Kewal for his many contributions at Pfizer. Under his leadership, Pfizer India became the first multi-national pharmaceutical company to enter the branded generics market, and became a leader in exploring unique partnerships with the government to increase market access.”

Tobaccowalla joined Wyeth in 1991 and held a number of business technology positions before joining leadership teams within Pfizer.

In 2009 he was appointed to his present role to lead the company's business technology function for all of its biopharmaceutical business units.

Pfizer employs over 2,300 people in India and in addition to its Mumbai HQ the company also has a manufacturing facility at Thane in Maharashtra.

2nd July 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...